Olive View DoM

Schaffer AJ, El-Harasis MA, Tinianow A, Azose A, Zalawadiya S, Dee K, Balsara K, Montgomery JA. Clinical Outcomes in Patients With Bacteremia and Concomitant Left[...]

By sjmartinez • April 22, 2023

Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Reply:[...]

By sjmartinez • April 20, 2023

Hanna C, Pettersen K, Pedley N. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023[...]

By sjmartinez • April 18, 2023

Koretz RL. JPEN Journal Club 77. Adjusting for confounders. JPEN J Parenter Enteral Nutr. 2023 Apr 8. doi: 10.1002/jpen.2505. Epub ahead of print. PMID: 37031359.

By sjmartinez • April 10, 2023

Malik A, Amjad W, Inayat F, Nadeem M, Weissman S, Malik MI, Jajja AA, Khan A, Tabibian JH. The effects of liraglutide on liver enzymes[...]

By sjmartinez • April 4, 2023

Law J, Trieu H, Kaleka G, Turkiewicz J, Palmer S, Lee JM, Chen KT, Tabibian JH. Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies[...]

By sjmartinez • March 30, 2023

LeVee A, Spector K, Larkin B, Dezem F, Plummer J, Dadmanesh F, Patil S, McArthur HL. Incidence and prognostic impact of HER2-positivity loss after dual[...]

By sjmartinez • March 28, 2023

Each year in mid-March, we experience anticipation and exhilaration in the department of medicine as we learn who will be coming to UCLA to train[...]

By sjmartinez • March 20, 2023

Koretz RL. JPEN Journal Club 76. Randomized crossover trials. JPEN J Parenter Enteral Nutr. 2023 Mar 4. doi: 10.1002/jpen.2496. Epub ahead of print. PMID: 36871066.

By sjmartinez • March 5, 2023

Koretz RL. JPEN Journal Club 72. The devil in the details. JPEN J Parenter Enteral Nutr. 2023 Mar;47(3):442-444. doi: 10.1002/jpen.2439. Epub 2022 Aug 29. PMID:[...]

By sjmartinez • March 4, 2023